Med. praxi. 2010;7(1):23-27

Fibromyalgia and fatigue syndrome - current status in diagnosing and treatment

doc.MUDr.Jaromír Bystroň, CSc.
Oddělení alergologie a klinické imunologie, Fakultní nemocnice Olomouc

The author presents a review article on recent knowledge in aetiopathogenesis, diagnosing and treatment of fibromyalgia and chronic

fatigue syndrome with a greater emphasis on chronic fatigue syndrome.

Keywords: fibromyalgia, chronic fatigue syndrome

Published: April 22, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bystroň J. Fibromyalgia and fatigue syndrome - current status in diagnosing and treatment. Med. praxi. 2010;7(1):23-27.
Download citation

References

  1. Hrnčíř Z, Dvořák Z. Fibromyalgie a chronický únavový syndrom. In: Pavelka K, Rovenský J, eds. Klinická revmatologie. Galen, 2003.
  2. Hrnčíř Z. Normativní přístup k syndromu generalizované fibromyalgie. Čes. Revmatol. 2009; 17: 99.
  3. Fučíková T. Chronický únavový syndrom versus chronický únavový stav. Klin. Imunol. Alergol, 1998; 8: 14-20.
  4. Tomš J. Co je nového v etiopatogenezi fibromyalgie? Čes. Revmatol. 2009; 17: 99.
  5. Racciatti D, Vecchiet J, Ceccomancini A, et al. Chronic fatique syndrome a toxic exposure. Sci Total Environ, 2001; 270(1-3): 27-31. Go to original source... Go to PubMed...
  6. Staines DR. Is chronic fatique syndrome an autoimmune disorder of endogenous neuropeptides, exogenous infection and molecular mimicry? Med Hypothese 2004; 62(5): 646-652. Go to original source... Go to PubMed...
  7. Steines DR. Is fibromyalgia an autoimmune disorder of endogenous vasoactive peptides? Med Hypoptheses. 2004; 62(5): 665-669. Go to original source... Go to PubMed...
  8. Appel S, Chapman J, Shoenfeld Y. Infection and vaccination in chronic fatique syndrome: myth or reality? Autoimmunity 2007; 40(1): 48-53. Go to original source... Go to PubMed...
  9. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatique syndrom. A working case definition. Ann. Inter. Med. 1988; 108: 387-389. Go to original source... Go to PubMed...
  10. Adler RH, Chronic fatique syndrome (CFS). Weiss Med Wkly 2004; 134(19-20): 268-276.
  11. Carlo-Stella N, Badulli C, De Silvestri A, et al. A first study of cytokine genomic polymorphisms in VFS: Positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol 2006; 24(2): 179-182. Go to PubMed...
  12. Dietert RR, Dietert JM. Possible role for early-life immune inzult including development immunotoxicity in chronic fatique syndrome/CFS) or myalgic encephalomyelitis (ME). Toxikology 2008; 247(1): 61-72. Go to original source...
  13. Janal MN, Ciccone DS, Natelson BH. Sub-typing CFS on the basis of, ,minor" symptoms. Biol. Psychol 2006. Go to original source...
  14. Maes M, Mihaylova I, Leunis JC. Increased serum IgA and IgM against LPS of enterobacteria in chronic fatique syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinalpermeability. J Affect Disord 2007; 99(1-3): 237-240. Go to original source... Go to PubMed...
  15. Maes M, Mihaylova I, Kubera M, Leunis JC. An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatique syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbity between major depression and CFS. Neuro Endocrinol Lett 2008; 29(3): 313-319. Go to PubMed...
  16. Vermeulen RC, Scholte HR. Azitromycin in chronic fatique syndrome (CFS), an analysis of clinical data. J Transl Med 2006; 15(4): 34. Go to original source... Go to PubMed...
  17. Bystroň J, Vidinová H, Masnikosová P, et al. Komplexní vyšetření pacientů s chronickou únavou. Prakt. Lékáren. 1999; 79(7): 408-411.
  18. Jarošová H. Možnosti léčby fibromyalgie. Čes. Revmatol. 2009; 17: 100.
  19. Bystroň J. Chronická únava a chronický únavový syndrom. Interní Med. pro praxi 2006; 8(3): 212-215.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.